Diverse, fiber-rich diets can help shape a TMAO-lowering microbiome
As 2024 drew to a close, Englands NICE finalised its guidance for Mounjaro, recommending its use in the primary care setting, for treating adults with a body mass index (BMI) 35 kg/m2 and at least one weight-related co-morbidity, alongside a reduced-calorie diet and increased exercise, with no restriction on treatment duration, equating to a total eligible population of 3.4 million patients [5]
Centers for Disease Control and Prevention
While starting prices look competitive, the jump from entry-level to maintenance doses is significant
36 Some of the other emerging pain management candidates in development include AT-121, ML-351, RTI-5152-12, and a Nav1.7 gene therapy
SNAQ puts the trend right next to your meals, so your progress and your eating sit in one view